Some deep mycoses prevalent in the United Arab Republic.
D000196:Actinomycosis / Q000188:drug therapy; D000666:Amphotericin B / Q000627:therapeutic use; D001759:Blastomycosis / Q000188:drug therapy; D003047:Coccidioidomycosis / Q000188:drug therapy; D004534:Egypt; D005534:Foot Diseases / Q000188:drug therapy / Q000601:surgery; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D008271:Mycetoma / Q000188:drug therapy / Q000601:surgery; D009181:Mycoses / Q000453:epidemiology; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D011193:Potassium Iodide / Q000627:therapeutic use; D013174:Sporotrichosis / Q000188:drug therapy; D013266:Stilbamidines / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013416:Sulfamerazine / Q000627:therapeutic use
D010406:Penicillins; D013266:Stilbamidines; D013411:Sulfadiazine; D011193:Potassium Iodide; D000666:Amphotericin B; D013416:Sulfamerazine